Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model

By sjmartinez • October 16, 2023

Iannone V, Babu AF, Lok J, Gómez-Gallego C, D'Auria G, Vazquez-Uribe R, Vaaben TH, Bongers M, Mikkonen S, Vaittinen M, Tikkanen I, Kettunen M, Klåvus A, Sehgal R, Kaminska D, Pihlajamaki J, Hanhineva K, El-Nezami H, Alexander Sommer MO, Kolehmainen M. Changes in liver metabolic pathways demonstrate efficacy of the combined dietary and microbial therapeutic intervention in MASLD mouse model. Mol Metab. 2023 Oct 13:101823. doi: 10.1016/j.molmet.2023.101823. Epub ahead of print. PMID: 37839774.

Tags: aldafermin, Cardiology/Epi, genetically modified E. coli Nissle 1917, Metabolic dysfunction-associated steatotic liver disease, non-alcoholic fatty liver disease, non-targeted metabolomics, omics integration, Publications, Transcriptomics

Heart Failure and Gut Microbiota: What Is Cause and Effect?

Shen S, Tian B, Zhang H, Wang YC, Li T, Cao Y. Heart Failure and Gut Microbiota: What Is Cause and Effect? Research (Wash D[...]

Amara Yad Image: Myocardial Scar

Mori S, Fishbein MC, Shivkumar K. Amara Yad Image: Myocardial Scar. J Am Coll Cardiol. 2025 Feb 25;85(7):782-783. doi: 10.1016/j.jacc.2025.01.004. PMID: 39971411.

Comparative Predictors of Mortality Risk in Contemporary Patients Referred for Stress Myocardial Perfusion Imaging

Rozanski A, Gransar H, Miller RJH, Han D, Hayes SW, Friedman JD, Thomson L, Lavie CJ, Berman DS. Comparative Predictors of Mortality Risk in Contemporary[...]